HIGHLIGHTS
- who: Bile acid and collaborators from the Experimental Hepatology and Drug Targeting (HEVEPHARM), University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain have published the research work: Etiopathogenesis and pathophysiology of cholestasis, in the Journal: (JOURNAL)
- what: The possibility to advance in the understanding of the pathogenic mechanism has fostered the investigation in search of more efficient and selective therapeutic strategies aimed at either correcting the underlying dysfunction, ameliorating the collateral alterations, which can prevent further life-threatening liver damage, or at least, improving the quality of life of these patients.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.